anti-Cytochrome P450 2B1,2B2 antibody product blog
Tags: Antibody; Monoclonal Antibody; Cytochrome P450 2B1,2B2; anti-Cytochrome P450 2B1,2B2 antibody;
The Cytochrome P450 2B1,2B2 n/a (Catalog #MBS603431) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Cytochrome P450 2B1,2B2 reacts with Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s Cytochrome P450 2B1,2B2 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in ELISA and Western Blot.
Dilution: Western Blot: 1:100 yields a strong band with 10ug of phenobarbital induced rat microsomes using alkaline phosphatase.
Optimum dilutions to be determined by researcher. Researchers should empirically determine the suitability of the Cytochrome P450 2B1,2B2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Phase 1 drug metabolism is catalyzed by two groups of monooxygenases, the cytochrome P450s (CYPs) and the flavin monooxygenases (FMOs). Both CYPs and FMOs are localized in the endoplasmic reticulum. Collectively, these enzymes catalyze the oxidation of a very broad range of substrates. Both classes are dependent on NADPH as a source of electrons, but the two classes exhibit significant differences in mechanism and substrate specificity.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Cytochrome P450 2B1,2B2 are readily searchable from our website. Different antibodies against the same target such as Cytochrome P450 2B1,2B2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.